GEP20156247B - Novel dihydrobenzoxathiazepine derivatives, preparation thereof, and pharmaceutical compositions containing them - Google Patents
Novel dihydrobenzoxathiazepine derivatives, preparation thereof, and pharmaceutical compositions containing themInfo
- Publication number
- GEP20156247B GEP20156247B GEAP201113048A GEAP2011013048A GEP20156247B GE P20156247 B GEP20156247 B GE P20156247B GE AP201113048 A GEAP201113048 A GE AP201113048A GE AP2011013048 A GEAP2011013048 A GE AP2011013048A GE P20156247 B GEP20156247 B GE P20156247B
- Authority
- GE
- Georgia
- Prior art keywords
- preparation
- pharmaceutical compositions
- dihydrobenzoxathiazepine
- derivatives
- novel
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 102000003678 AMPA Receptors Human genes 0.000 abstract 1
- 108090000078 AMPA Receptors Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
There are represented compound of formula (I), preparation method thereof, pharmaceutical compositions on basis thereof, and their application as AMPA receptor modulators.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1003683A FR2964969B1 (en) | 2010-09-16 | 2010-09-16 | NOVEL DIHYDROBENZOXATHIAZEPINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Publications (1)
Publication Number | Publication Date |
---|---|
GEP20156247B true GEP20156247B (en) | 2015-02-10 |
Family
ID=43067253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GEAP201113048A GEP20156247B (en) | 2010-09-16 | 2011-09-15 | Novel dihydrobenzoxathiazepine derivatives, preparation thereof, and pharmaceutical compositions containing them |
Country Status (40)
Country | Link |
---|---|
US (1) | US8569285B2 (en) |
EP (1) | EP2431360B1 (en) |
JP (1) | JP2013537216A (en) |
KR (1) | KR20130054438A (en) |
CN (1) | CN103153973A (en) |
AP (1) | AP2013006793A0 (en) |
AR (1) | AR082973A1 (en) |
AU (1) | AU2011213898A1 (en) |
BR (1) | BR112013005967A2 (en) |
CA (1) | CA2752131C (en) |
CL (1) | CL2013000655A1 (en) |
CO (1) | CO6680709A2 (en) |
CR (1) | CR20130105A (en) |
CU (1) | CU20130037A7 (en) |
CY (1) | CY1114110T1 (en) |
DK (1) | DK2431360T3 (en) |
EA (1) | EA201300340A1 (en) |
EC (1) | ECSP13012489A (en) |
ES (1) | ES2421504T3 (en) |
FR (1) | FR2964969B1 (en) |
GE (1) | GEP20156247B (en) |
GT (1) | GT201300067A (en) |
HR (1) | HRP20130505T1 (en) |
IL (1) | IL225209A0 (en) |
MA (1) | MA34529B1 (en) |
ME (1) | ME01524B (en) |
MX (1) | MX2013002892A (en) |
NI (1) | NI201300028A (en) |
PE (1) | PE20131342A1 (en) |
PL (1) | PL2431360T3 (en) |
PT (1) | PT2431360E (en) |
RS (1) | RS52835B (en) |
SA (1) | SA111320755B1 (en) |
SG (1) | SG188380A1 (en) |
SI (1) | SI2431360T1 (en) |
TW (1) | TWI421080B (en) |
UA (1) | UA105320C2 (en) |
UY (1) | UY33574A (en) |
WO (1) | WO2012035216A1 (en) |
ZA (1) | ZA201106353B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111518058B (en) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | Oxathiazine compound and application thereof |
CN111559990B (en) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | Micromolecular oxathiazine derivative and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EE200000468A (en) * | 1998-02-18 | 2002-04-15 | Neurosearch A/S | The compounds, their use and the pharmaceutical composition |
TWI232863B (en) * | 2001-06-11 | 2005-05-21 | Akzo Nobel Nv | Benzoxazepine derivatives |
IL158928A0 (en) * | 2001-06-14 | 2004-05-12 | Akzo Nobel Nv | (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES |
FR2856064B1 (en) * | 2003-06-13 | 2005-08-19 | Servier Lab | NOVEL BENZOTHIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
-
2010
- 2010-09-16 FR FR1003683A patent/FR2964969B1/en not_active Expired - Fee Related
-
2011
- 2011-08-24 UY UY0001033574A patent/UY33574A/en unknown
- 2011-08-25 AU AU2011213898A patent/AU2011213898A1/en not_active Abandoned
- 2011-08-30 ZA ZA2011/06353A patent/ZA201106353B/en unknown
- 2011-09-07 TW TW100132314A patent/TWI421080B/en not_active IP Right Cessation
- 2011-09-07 CA CA2752131A patent/CA2752131C/en not_active Expired - Fee Related
- 2011-09-14 AR ARP110103332A patent/AR082973A1/en unknown
- 2011-09-14 SA SA111320755A patent/SA111320755B1/en unknown
- 2011-09-15 SI SI201130030T patent/SI2431360T1/en unknown
- 2011-09-15 JP JP2013528735A patent/JP2013537216A/en active Pending
- 2011-09-15 KR KR1020137009580A patent/KR20130054438A/en not_active Application Discontinuation
- 2011-09-15 WO PCT/FR2011/000502 patent/WO2012035216A1/en active Application Filing
- 2011-09-15 PE PE2013000377A patent/PE20131342A1/en not_active Application Discontinuation
- 2011-09-15 BR BR112013005967A patent/BR112013005967A2/en not_active Application Discontinuation
- 2011-09-15 RS RS20130274A patent/RS52835B/en unknown
- 2011-09-15 EA EA201300340A patent/EA201300340A1/en unknown
- 2011-09-15 AP AP2013006793A patent/AP2013006793A0/en unknown
- 2011-09-15 MX MX2013002892A patent/MX2013002892A/en active IP Right Grant
- 2011-09-15 UA UAA201304534A patent/UA105320C2/en unknown
- 2011-09-15 ES ES11290413T patent/ES2421504T3/en active Active
- 2011-09-15 SG SG2013015904A patent/SG188380A1/en unknown
- 2011-09-15 DK DK11290413.1T patent/DK2431360T3/en active
- 2011-09-15 GE GEAP201113048A patent/GEP20156247B/en unknown
- 2011-09-15 EP EP11290413.1A patent/EP2431360B1/en active Active
- 2011-09-15 PL PL11290413T patent/PL2431360T3/en unknown
- 2011-09-15 MA MA35744A patent/MA34529B1/en unknown
- 2011-09-15 ME MEP-2013-82A patent/ME01524B/en unknown
- 2011-09-15 CN CN2011800437978A patent/CN103153973A/en active Pending
- 2011-09-15 PT PT112904131T patent/PT2431360E/en unknown
- 2011-09-15 US US13/200,045 patent/US8569285B2/en not_active Expired - Fee Related
-
2013
- 2013-03-08 CL CL2013000655A patent/CL2013000655A1/en unknown
- 2013-03-11 CR CR20130105A patent/CR20130105A/en unknown
- 2013-03-12 CO CO13049160A patent/CO6680709A2/en not_active Application Discontinuation
- 2013-03-14 NI NI201300028A patent/NI201300028A/en unknown
- 2013-03-14 CU CU2013000037A patent/CU20130037A7/en unknown
- 2013-03-14 GT GT201300067A patent/GT201300067A/en unknown
- 2013-03-14 IL IL225209A patent/IL225209A0/en unknown
- 2013-03-15 EC ECSP13012489 patent/ECSP13012489A/en unknown
- 2013-06-07 HR HRP20130505AT patent/HRP20130505T1/en unknown
- 2013-07-03 CY CY20131100553T patent/CY1114110T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2010246749A8 (en) | Thiophene derivatives | |
MX2011008864A (en) | Sulfonylated tetrahydroazolopyrazines and their use as medicinal products. | |
PH12015501996A1 (en) | Heterocyclic compounds and uses thereof | |
NZ705213A (en) | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof | |
GEP20156318B (en) | Heteroaryl derivatives as alpha7 nachr modulators | |
MY172156A (en) | Modulators of methyl modifying enzymes, compositions and uses thereof | |
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
PH12015500491A1 (en) | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof | |
MX2011005934A (en) | Organic compounds. | |
MX2010007587A (en) | Compounds comprising a cyclobutoxy group. | |
MX348862B (en) | C4-monomethyl triterpenoid derivatives and methods of use thereof. | |
NZ703162A (en) | Heterocyclic modulators of lipid synthesis | |
IN2012DN02984A (en) | ||
GEP20135862B (en) | Novel benzothiadiazepine compounds, method of their preparation, and pharmaceutical compositions containing thereof | |
IN2012DN05125A (en) | ||
CA2818986A1 (en) | Indole derivatives as modulators of s1p receptors | |
GEP201706710B (en) | Imidazopyridazine derivatives as gabaa receptor modulators | |
GEP20186911B (en) | Substituted chroman compounds as calcium sensing receptor modulators | |
MY169267A (en) | New aryl-quinoline derivatives | |
MX364069B (en) | Flap modulators. | |
CA2891755C (en) | Substituted pyrido-piperazinone derivatives as gamma secretase modulators | |
EA201200616A1 (en) | DERIVATIVES 2-OXO-1-PIRROLIDININILIMIDAZOTHIAADIA ASOL | |
WO2012071212A3 (en) | Novel phosphonic acids as s1p receptor modulators | |
WO2011050054A3 (en) | Coumarin compounds as receptor modulators with therapeutic utility | |
GEP20156247B (en) | Novel dihydrobenzoxathiazepine derivatives, preparation thereof, and pharmaceutical compositions containing them |